Chemoradiotherapy improves survival in some elderly patients with head, neck cancer

The addition of chemotherapy to radiation therapy improved survival among elderly patients with head and neck cancer who were aged 71 to 79 years and had low comorbidity scores, according to findings presented at the Multidisciplinary Head and Neck Cancers Symposium.